IRL757 clinical trials

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

This study is testing a new medicine, IRL757, for people with Parkinson's disease who also have apathy (a lack of interest or drive). Researchers want to see if the medicine is safe, well-tolerated, and if it helps with Parkinson's symptoms. Some people will get the real medicine, others a dummy pill.